Arrowhead Pharmaceuticals Inc. buy B. Riley
Start price
14.02.25
/
50%
€18.85
Target price
14.02.26
€36.16
Performance (%)
-23.71%
Price
13:51
€14.38
Summary
This prediction is currently active. The prediction for Arrowhead Pharmaceuticals Inc. disappoints with a performance of -23.71%. This prediction currently runs until 14.02.26. The prediction end date can be changed by B__Riley at any time. B__Riley has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Arrowhead Pharmaceuticals Inc. | 1.897% | 1.897% |
| iShares Core DAX® | -0.695% | 0.275% |
| iShares Nasdaq 100 | -0.520% | 3.779% |
| iShares Nikkei 225® | 0.870% | 1.365% |
| iShares S&P 500 | -0.737% | 3.346% |
Comments by B__Riley for this prediction
In the thread Arrowhead Pharmaceuticals Inc. diskutieren
Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) had its "buy" rating re-affirmed by analysts at B. Riley. They now have a $38.00 price target on the stock, down previously from $51.00.
Ratings data for ARWR provided by MarketBeat
Stopped prediction by B__Riley for Arrowhead Pharmaceuticals Inc.
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€21.28
12.08.24
12.08.24
€50.31
12.08.25
12.08.25
-33.36%
13:51
13:51
Arrowhead Pharmaceuticals Inc.
Start price
Target price
Perf. (%)
€31.22
20.07.23
20.07.23
€49.32
20.07.24
20.07.24
-17.26%
21.07.24
21.07.24